Leading new pharmacological design platform The state of entrepreneurship was informed that in May 2023, Nanjing Yukio Takasu Biosciences Ltd. (hereinafter referred to as “Rede clouds”) announced the completion of nearly 100 million yuan renminbi B+ swaps, co-sponsored by the Dutch ponds, the Qana Bank of Thailand, the Ingkin and Ttato Foundation, and the ongoing holding of the current shareholder Chariba investment. Kai is capitalized as the sole financial adviser for the current round. The ...